Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicentric development and evaluation of [18F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy.
Lucia F, Louis T, Cousin F, Bourbonne V, Visvikis D, Mievis C, Jansen N, Duysinx B, Le Pennec R, Nebbache M, Rehn M, Hamya M, Geier M, Salaun PY, Schick U, Hatt M, Coucke P, Hustinx R, Lovinfosse P. Lucia F, et al. Among authors: salaun py. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1097-1108. doi: 10.1007/s00259-023-06510-y. Epub 2023 Nov 21. Eur J Nucl Med Mol Imaging. 2024. PMID: 37987783
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY. Abgral R, et al. Among authors: salaun py. J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17. J Nucl Med. 2009. PMID: 19091901 Free article. Clinical Trial.
Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?
Salaun PY, Gastinne T, Bodet-Milin C, Campion L, Cambefort P, Moreau A, Le Gouill S, Berthou C, Moreau P, Kraeber-Bodéré F. Salaun PY, et al. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1813-21. doi: 10.1007/s00259-009-1183-0. Epub 2009 Jun 5. Eur J Nucl Med Mol Imaging. 2009. PMID: 19499219
Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.
Le Roux PY, Gastinne T, Le Gouill S, Nowak E, Bodet-Milin C, Querellou S, Mahe B, Dubruille V, Blin N, Salaun PY, Bodere-Kraeber F. Le Roux PY, et al. Among authors: salaun py. Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1064-71. doi: 10.1007/s00259-011-1741-0. Epub 2011 Feb 10. Eur J Nucl Med Mol Imaging. 2011. PMID: 21308370
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.
Abgral R, Le Roux PY, Keromnes N, Rousset J, Valette G, Gouders D, Leleu C, Mollon D, Nowak E, Querellou S, Salaün PY. Abgral R, et al. Among authors: salaun py. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1839-47. doi: 10.1007/s00259-012-2213-x. Epub 2012 Aug 16. Eur J Nucl Med Mol Imaging. 2012. PMID: 22895863 Clinical Trial.
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
Salaun PY, Campion L, Ansquer C, Frampas E, Mathieu C, Robin P, Bournaud C, Vuillez JP, Taieb D, Rousseau C, Drui D, Mirallié E, Borson-Chazot F, Goldenberg DM, Chatal JF, Barbet J, Kraeber-Bodéré F. Salaun PY, et al. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1501-10. doi: 10.1007/s00259-014-2772-0. Epub 2014 May 8. Eur J Nucl Med Mol Imaging. 2014. PMID: 24806110 Clinical Trial.
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.
Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, Binns D, Desmonts C, Salaun PY, Hicks RJ, Aide N. Quak E, et al. Among authors: salaun py. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2072-82. doi: 10.1007/s00259-015-3128-0. Epub 2015 Jul 30. Eur J Nucl Med Mol Imaging. 2015. PMID: 26219870 Free PMC article.
Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A, Calais J, Robin P, Thureau S, Bourhis D, Modzelewski R, Schick U, Vera P, Salaün PY, Abgral R. Chaput A, et al. Among authors: salaun py. Head Neck. 2017 Jun;39(6):1155-1165. doi: 10.1002/hed.24738. Epub 2017 Mar 6. Head Neck. 2017. PMID: 28263422
162 results